|
3M submitted additional data on perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA), and related compounds to the EPA, including several studies on their effects and a correction regarding a previously misidentified test substance.
|
2008 |
AR226-3802
|
5kNBNvdVOYbL38708vr1RMRYN |
2 |
|
The report details a cohort mortality study of employees at the 3M Ammonium Perfluorooctanoate (APFO) production facility in Cottage Grove, Minnesota, investigating the relationship between varying levels of APFO exposure and specific causes of death among workers from their employment start until 2002.
|
2007 |
AR226-3802
|
QkyXwG2JXm8kmgOY95ExMMra4 |
52 |
|
This document reports on an acute toxicity test of perfluorooctanesulfonate (PFOS) using spiked sediment with the test organism Chironomus tentans, conducted under GLP conditions, which determined the substance's effects on survival and ash-free dry weight over a 10-day exposure period.
|
2007 |
AR226-3802
|
0MyX7nvr8XjwNj99Y2BYOrqJ |
6 |
|
The report examines the mortality rates of employees at the 3M Ammonium Perfluorooctanoate (APFO) production facility in Cottage Grove, Minnesota, analyzing potential associations between APFO exposure and causes of death among workers employed prior to 1997.
|
2007 |
AR226-3802
|
e5N226MM4JXrnQ80aDq9nRX6e |
52 |
|
This document is the final report for a developmental neurotoxicity and thyroid function study of MTDID 208, conducted by WIL Research Laboratories for 3M Corporation, which complied with EPA guidelines but noted some non-GLP conditions in specific analyses.
|
2006 |
AR226-3802
|
6w2BBkZzLR24Gb5jBQkbyMjB4 |
2200 |
|
The document is a report from CXR Biosciences detailing a 4-week study sponsored by 3M to investigate the effects of perfluorooctane sulfonate (PFOS) on hepatomegaly in male Sprague Dawley rats.
|
2006 |
AR226-3802
|
xGXVkVOy3R3QX9ByaeeaaYME |
153 |